www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Companies

US company partners with Chinese firm to tackle rare disease

Xinhua | Updated: 2017-09-27 09:13

SHANGHAI — Staff with US company Amicus Therapeutics regularly travel to Shanghai to work out how to develop a new drug to treat Pompe disease, a rare muscle disorder.

John Crowley, chief executive of the company, led the recent trip to its Chinese partner WuXi Biologics, based in Shanghai.

Crowley said the new drug was expected to reduce the side effects of existing enzyme replacement therapy.

The disorder prevents the human body from making enough of an enzyme used by heart and muscle cells to convert a form of sugar called glycogen into energy. When glycogen builds up in these cells it can lead to swelling of the heart, disability and early death.

Crowley has led a personal struggle to save his daughter and son, who are afflicted with Pompe disease.

Crowley said his company chose WuXi Biologics as its contract manufacturer, even though some company board members questioned the decision, doubting such high-quality drugs could be made by a Chinese firm.

Currently, the drug is in stage two of clinical trials, and around 20 patients are being tested with the drug in the United States.

By the middle of next year, it is expected to enter stage three, and be applied to more patients for tests, Crowley said.

Chinese patients are expected to be included in the trials, he said. Gao Ru, founder of a Chinese Pompe patient association, said the cooperation would benefit Chinese patients. She estimated there are about 35,000 Pompe patients in China.

Gao said she managed to contact about 100 of them, 80 percent of whom were adults, and 20 percent babies.

For an adult patient, the annual medical cost is around 3 million yuan (about $460,000).

"I hope the cost for the prescription can be reduced," she said.

Crowley helped founded Novazyme, a company working on Pompe disease treatment. The company was was acquired by Genzyme in 2011. Now Paris-based Sanofi SA owns the drugs. He later founded Amicus Therapeutics to develop therapy for rare disease including Pompe.

"If you compare ordinary drugs to a bicycle, bio-medicine is like a plane. It is very difficult to make," said Chen Zhisheng, CEO of WuXi Biologics.

"The new generation drugs to treat Pompe diseases needs to be very accurate in dealing with the disorder. Both our companies will be committed to the development of the drugs until they are put on the market and bring benefits to patients," Chen said.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 波多野结衣在线观看一区 | 欧美成人一级 | 国产成人综合网在线观看 | 手机看片国产免费久久网 | 日本高清视频在线观看 | 窝窝午夜精品一区二区 | 亚洲第一在线 | 成人免费午夜性视频 | 国产视频三区 | 成年人免费大片 | 成年网站视频在线观看 | 久草视频在线网 | 欧美一级香蕉毛片 | 99精品久久精品一区二区 | 欧美成人www在线观看网页 | 午夜性刺激免费视频 | 欧美一级做一a做片性视频 欧美一级做一级爱a做片性 | 亚洲精品日韩中文字幕久久久 | 国产欧美自拍视频 | 99热久久国产这里是精品 | 久草青青 | 久草在在线视频 | 亚洲精品久久一区毛片 | www.亚洲天堂.com | 国产精品线在线精品国语 | 亚洲网站一区 | 国产高清视频在线 | 久久精品视频免费在线观看 | 中文字幕一区2区 | 国产成人免费高清视频网址 | 爱综合| 日韩在线观看不卡 | 亚洲人成a在线网站 | 男女午夜爽爽 | 欧美一区二区在线视频 | 欧美亚洲免费 | 台湾三级香港三级在线中文 | 精品成人在线 | 国产精品日韩欧美 | 国产亚洲精品午夜高清影院 | 国产草草影院ccyycom软件 |